https://techcrunch.com/2023/10/24/signos-series-b/

Signos, a metabolic health platform that utilizes a unique AI-engine with a continuous glucose monitor (CGM) to offer real-time data and recommendations for healthy weight management, has announced a successful $20 million Series B funding round. The round was led by Cheyenne Ventures and GV (Google Ventures), with additional investments from Dexcom Ventures and Samsung. It will enable Signos to expand its team, extend its platform and conduct further research on metabolic health.

Signos set itself the mission of addressing the obesity and metabolic health crisis that currently afflicts the United States. With more than 96 million Americans prediabetic and an estimated 1 billion people projected to have diabetes by 2050, the company says the need for early detection and lifestyle changes is more critical than ever.